What if we say that the United States of America has secret biolabs all around the world where some of the most hideous and horrific experiments are conducted, and this includes Africa, where disturbing and unethical experiments take place? However, these reports are often dismissed as rumors due to the perspective created by the United States that such biolabs and their horrific experiments only exist in fictional movies. Nevertheless, it is disconcerting to discover that these biolabs are indeed a reality.

The question arises: what occurs within these facilities, and why does the United States keep them hidden from the world? If all of the United States' biological laboratories were located within its borders, it might not raise as much concern. However, research reveals that the US is the sole country with dispersed biolabs globally, including over 30 in Africa and more than 400 worldwide. This raises further questions about why a country like the United States would require such an extensive network of biolabs, particularly those conducting top secret and human-related experiments.

Following pandemics like COVID-19 and viral diseases such as AIDS, evidence has emerged linking these outbreaks to experiments conducted in biolabs. The initial US biolabs in Africa, established in the late 1990s to combat AIDS and malaria, have expanded to over 400 units. While the US claims its focus is on researching global biological threats and finding solutions, suspicions persist that these activities could serve as a cover for the research and development of bioweapons, expanding their existing arsenal. During the Russia-Ukraine war, the Russian Defense Ministry accused the US of utilizing Ukrainian laboratories to develop biological weapons, intending to distribute them through migratory birds and diseased bats.

The US denied these allegations, dismissing them as misinformation. However, documents obtained by Robert Kennedy Jr. revealed US military-funded labs in Ukraine engaged in creating biological weapon components and testing them on the local population. In 2023, Robert Kennedy, a US politician, acknowledged the existence of US biolabs producing illegal bioweapons in Ukraine. Later, the US officially admitted to running biolabs in Ukraine, exposing their previous denials as lies.

This further demonstrates that the US's denial of having biolabs worldwide is also false.

By October 2023, the Russian defense once again expressed concerns, arguing that the US was transferring its dual-use biological research to Africa. These developments raise serious questions about the intentions and activities of the United States in operating biolabs globally, particularly in Africa. There are growing suspicions that the United States is conducting unlawful and dangerous experiments involving potential bioweapons in African countries, despite consistent denials by the US. Doubts remain about the validity of their claims.

Dr. Ntsikelelo Benjamin Breakfast, a senior lecturer at Nelson Mandela University in South Africa, suggests that the US may be shifting its biological research to Africa to increase its influence on the continent. Africa's strategic importance as a geopolitical battleground due to its abundant resources makes it an attractive location for the US.

Dr. Benjamin believes that considering the presence of US military bases in Africa, the biolabs could easily integrate into the existing military infrastructure. This raises concerns about the necessity of dismantling foreign military bases on the continent.

The Russian report on US labs in Africa also suggests that one reason for establishing biolabs on the continent is the ease with which the US can conduct experiments on the local population with minimal resistance. Additionally, conducting experiments in Africa is considered more cost-effective and carries fewer reputational risks for the US. While these US labs may appear to be aimed at combating deadly diseases, they actually pose a threat to the African continent. Imagine the catastrophic consequences if strains of deadly diseases—such as viruses or pathogens—were to escape the lab, especially in a region lacking the expertise and equipment needed to contain such diseases. Interestingly, there have been multiple incidents along these lines. According to reports by experts, whenever an epidemic outbreak has occurred in Africa, there are reports of a US lab located in close proximity.

In Liberia, for example, Dr. Cyril Brook, an expert in infection and microbiological diseases, has published articles condemning the United States for creating and spreading Ebola fever pathogens.

According to Dr. Brook, epidemic outbreaks have coincided with regions where American biological laboratories were present. He further alleges that the US is covertly involved in creating and spreading deadly viruses, asserting that Ebola and AIDS were genetically modified organisms developed by military organizations in North America as biological weapons, specifically targeted for testing in Africa. One specific case highlighted is the Kenema City State Hospital in Sierra Leone, where it is claimed that over 13,000 deaths occurred due to the Ebola virus as a result of covert American laboratory operations. Recent revelations have exposed the existence of a secret American laboratory, financially supported by the George Soros and Bill and Melinda Gates foundations.

Despite persistent denials by the US, evidence has emerged contradicting their assertions of using biolabs solely for non-weaponized experiments. These facilities operate under high security protocols and are shrouded in secrecy, which raises suspicions especially during disease outbreaks. This fuels an ongoing challenge in identifying the origin of epidemics. The Ebola virus outbreak is particularly concerning, as it involved specialists primarily composed of Europeans and Americans.

During the crisis, more than 250,000 blood samples were collected without patient consent, raising ethical concerns. These samples were then transported to Europe and the US for research, providing European and American pharmaceutical corporations with unauthorized genetic data from Africans. This controversial action resulted in substantial cost savings, amounting to billions of dollars in the development of a vaccine.

A disturbing case has emerged involving a Guinean woman identified as code C15. Her blood containing the Ebola virus is commercially accessible on the website of the European Virus Archive, housed at Germany's Bernhard Nocht Institute for Tropical Medicine. The price for accessing this blood sample is $3,637, surpassing the value of gold by 170 times. This highlights the unsettling reality that conducting bioresearch in Africa is more cost-effective and profitable for the West, which is willing to sell practically anything consumers can pay for. This ethical breach is further aggravated by the lack of compensation for those whose blood was taken without consent.

Notably, the exact number of collected blood samples remains undisclosed, with American and European medics citing national security concerns. This raises the question of how withholding this information aligns with national security interests. Complicating matters, despite the extensive collection of blood samples from African citizens, scientists from Sierra Leon, Liberia, and Guinea are denied access to conduct their own independent research. The US's refusal to grant access raises significant doubts about the selfless motives behind these bioresearch initiatives.

If the goal is genuinely for the benefit of Africa and the global community, denying access to African scientists raises valid concerns. The situation remains perplexing and worrisome. Recent reports reveal that Africa has the highest concentration of US biolabs, with Uganda emerging as a focal point of American interest. The United States has established a significant network, including medical research centers, institutes, medical schools, and biolabs, some of which are situated within prisons. According to these reports, American biologists conduct research on hazardous viral respiratory infections, often involving prisoners, seemingly without concern for potential repercussions.

In Uganda, the incidence of tuberculosis among prisoners reportedly exceeds that of the civilian population by three times. Officially, US labs in the region declare a mission to prevent and counter biohazards, emphasizing the protection of the local population. However, concerns arise due to their direct subordination to the Pentagon, which includes collecting materials and information from the local population and gathering DNA from African individuals. Despite global apprehensions regarding the associated risks of these biothreats, the United States has decided to expand its network of biological laboratories across the African continent.

The expansion of US biolabs raises concerns about the emergence of new bio[-]threats. Africa's perceived vulnerability makes it strategically appealing to the United States. International organizations such as the World Health Organization may face challenges in holding the Pentagon accountable, particularly since a significant portion of WHO's funding originates from the United States. It's important to note that the official US biological weapons program was initiated in the spring of 1943, following directives from President Franklin Roosevelt.

After World War II, spanning 27 years, the program accumulated a substantial stockpile of biological agents and weapons. This covert program involved laboratory and field testing, including the use of stimulants on individuals without their consent. The primary objective of the official US policy was to deter the use of bioweapons against US forces, with retaliation as a secondary focus if deterrence failed. In 1969, President Richard Nixon ended all offensive aspects of the US bioweapons program. By 1975, the US had ratified international treaties such as the 1925 Geneva Protocol and the 1972 Biological Weapons Convention, which outlawed biological warfare. However, despite signing these protocols, the US continued conducting experiments in biolabs for potential biological weapons development.

The US interest in biological warfare can be traced back to the aftermath of World War I, when tests involving ricin toxin from the castor plant were carried out in the early 1920s. Proposals for a US biological weapons program emerged within the Chemical Warfare Service [CWS]. However, the chief of the [CWS] dismissed such a program as unprofitable. During World War II, the US Army initially considered biological weapons impractical, in contrast to countries like France, Japan, and the United Kingdom. However, heightened interest in biological weapons in 1941 led to the creation of the War Bureau of Consultants [WBC] in response to Secretary of War Henry L. Stimson's request.

Under the influence of British pressure and the [WBC's] research findings, the establishment of an offensive biological weapons program was advocated for. In November 1942, President Franklin Roosevelt authorized the American biological weapons program, which was overseen by the War Research Service.

The US Army Biological Warfare Laboratories were established in 1943 at Fort Detrick, Maryland, initially subcontracted to universities. The program quickly expanded and came under the complete control of the Chemical Warfare Service. Additional facilities were constructed in Indiana, Mississippi, and Utah by November 1943. The public remained unaware of the program's existence until January 1946 due to effective security measures. During the Cold War period from 1947 to 1969, the US underwent a significant transformation in its biological warfare initiative.

The program shifted from a factory-level operation to a more secretive and contentious military-driven research and production endeavor. By 1950, Camp Detrick in Maryland became the primary US bioweapons facility, under the Research and Engineering Division of the US Army Chemical Corps. Production and testing also occurred at other locations like Pine Bluff, Arkansas, and Dugway Proving Ground, Utah. Biological warfare research expanded considerably during the Cold War, with both the US Army and the US Air Force enhancing their programs, particularly in delivery systems.

The US and the Soviet Union accumulated enough biological weapons to pose a global threat.

Legal proceedings, including the trial of John W. Powell, revealed the US Army's capability for both offensive and defensive biological and chemical weapons during a specific timeframe. The Kennedy-Johnson years witnessed an expansion phase, including the initiation of Project 112 in 1961, which involved covert field testing of biological weapons using simulants and agents dispersed over large areas.

Concerns arose, and scientists like Theodore Roseberry and Matthew Meselson voiced their opposition to the development of biological weapons. The Vietnam War brought public attention to the US biological weapons program, with international criticism over the use of chemicals like Agent Orange and controversial human research programs. In response to growing negative perceptions and the realization that biological weapons could be used as asymmetric warfare, the Nixon Administration took action.

In 1972, President Nixon unilaterally renounced the US biological warfare program, leading to the signing of the Biological and Toxin Weapons Convention. This marked the end of official US involvement in biological warfare. However, recent reports, including Russia's accusations and the US admitting to having biolabs in Ukraine, suggest that the US never truly ended its biological weapons development program.

While President Nixon publicly ended it, the Pentagon continued to carry out the program but with the difference of keeping it secret. The COVID-19 pandemic caused worldwide chaos, revealing how vulnerable global stability is to a challenging and hard-to-contain virus. It became clear that viruses can have a profound impact on the world economy, surpassing that of conventional warfare or military conflicts.

This realization has led to increased attention on organizations involved in biological research, particularly focusing on American facilities working on a COVID-19 vaccine. However, criticisms have emerged regarding transparency issues, as the US has maintained secrecy about these activities, while labs in other countries operate more openly. Covert research centers allegedly funded by the United States are reportedly located in Eastern Europe, Central Asia, and Africa.

Some experts even suggest that American involvement may have played a role in triggering the Ebola outbreak. US laws stipulate that any biological research conducted by American laboratories must be solely for civilian purposes and pose no threat to local populations. Efforts are underway to uncover the truth and understand the actual activities taking place within US-funded African biological laboratories. The first US laboratories in Africa were established in the late '90s, primarily focused on combating AIDS and malaria. However, concerns have arisen over the proliferation of these facilities and their potential connection to epidemic outbreaks in specific African regions.

Dr. Krill Broderick, an expert in infections and microbiological diseases, published articles in Liberia's largest newspaper, the Liberian Observer, condemning the US for allegedly creating and spreading Ebola fever pathogens. He claimed that epidemic outbreaks coincided with the presence of American biological laboratories and suggested that Ebola and AIDS were genetically modified organisms developed by North American military organizations as biological weapons, intentionally introduced to Africa for testing. Various sources have reported alternative versions of the spread of the Ebola virus.

Some American alternative media outlets have highlighted an emergency at Kenema City State Hospital in Sierra Leone during an Ebola outbreak, which claimed over 13,000 lives. The hospital was said to house an American laboratory funded by George Soros and the Bill & Melinda Gates Foundations. The existence of these biolabs presents a significant potential threat, as any system failure could have catastrophic consequences for individual countries and the entire world. The accidental release of a biological weapon, causing mass casualties, is a major concern.

However, proving the involvement of American foundations in these activities can be challenging. Africa is home to a vast network of medical research centers with diverse missions. These laboratories engage in tasks such as discovering, studying, and classifying natural pathogens like viruses, bacteria, and fungi. They also conduct research on pathogen genomes and mutations, develop vaccines, test their efficacy, and ensure their preservation. The US State Department has affirmed that American biological laboratories collaborate with local African authorities to detect and protect new disease cases, manage epidemiological situations, and investigate outbreaks.

There are at least 30 American biolabs in Africa, officially focused on preventing and countering biohazards to protect the local population. However, these labs operate under the jurisdiction of the Pentagon. Their involvement extends to comprehensive preparations for disease studies, including collecting materials and information from the local population and gathering DNA from African individuals. This data is then transmitted to the Defense Threat Reduction Agency (DTRA), which is controlled by the Pentagon and plays a crucial role in the US defense system for chemical and biological research.

The DTRA has established an extensive network of medical facilities in over 25 countries, including regions like Iraq, Afghanistan, Pakistan, Jordan, Laos, Myanmar, the Philippines, Ukraine, Georgia, Kazakhstan, Tajikistan, Uzbekistan, and various African states. Some of these medical centers have been directly established by the DTRA, and their activities receive funding from the agency. The DTRA frequently deploys military biologists to civilian laboratories in collaboration with the US Department of Health and Human Services (HHS) or private contractors.

These contractors operate with limited oversight from the US Congress, enjoying a degree of autonomy. Although the Biological Weapons Convention, adopted in 1972, mandates the US to share biological defense information annually with other nations, the level of transparency remains a subject of concern. The secrecy surrounding US biological research in various biolabs worldwide has raised concerns and led to speculation about the nature of their activities. Some programs with dubious reputations are often assigned to entities like the CIA, HHS, or private contractors, allowing for a complex approach to concealing US biological research.

For example, the CH2M Hill company oversees multiple biological research programs connected to the Pentagon, CIA, and other government structures. They hold a $341.5 million contract with the DTRA as part of the Pentagon's Uganda biolabs program. This intricate web of organizations involved in US biological research arises from strict legal regulations and significant financial investments. Notably, all experiments and tests in the United States must be exclusively conducted on animals.

As a result, major military centers and pharmaceutical companies engage in covert operations and biological research in third-world countries, utilizing the local population for cost-effective gathering of biological materials and vaccine testing. Africa, with its extensive network of medical research centers, many of which have ties to US Government structures, serves as a prime location of interest for the United States. Uganda, in particular, stands out as a focal point.

Documents outlining collaboration between Uganda's governmental bodies and Washington reveal a noticeable pattern. Most medical research centers, institutes, medical schools, and biolabs, including those within prisons, were established by the United States. These entities collectively form an interconnected network. For instance, the Defense Threat Reduction Agency (DTRA) of the US operates a laboratory in Arua City, northwest Uganda, in close proximity to a city prison also financially backed by the United States. This raises concerns that American biologists might be conducting research on dangerous viral respiratory infections using prisoners, seemingly without fearing consequences.

Furthermore, the DTRA funded the establishment of a biolab near Namulonge, central Uganda, in early 2019, under the supervision of the National Institute of Animal Husbandry. Its mission focuses on the early detection of Crimean-Congo hemorrhagic fever, brucellosis, and anthrax. The fact that this facility, funded by the Pentagon, operates within a civilian context raises suspicions, especially considering stringent security measures and undisclosed animal experiments. The activities of US biological laboratories in African countries remain shrouded in secrecy, making it challenging to gather comprehensive information. Based on available facts, it appears that under the guise of humanitarian efforts, American bioengineers collect DNA globally and subject unsuspecting individuals to tests with dangerous viruses. The results of these African tests are then sent to the United States.